SCHEMBL28484259

SCHEMBL28484259

C[C@@]1(O)[C@@H](O)[C@@H](CO)O[C@H]1n1cnc2c(N)nc(Cl)nc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 8/20 1.00
ADORA3 P0DMS8 11/20 0.67
ADORA1 P30542 7/20 0.67
ADORA2B P29275 3/20 0.67
ADA P00813 1/20 0.67
ALOX15 P16050 1/20 0.67
PDE4D Q08499 2/20 0.61
PDE3A Q14432 2/20 0.61
PNP P00491 1/20 0.61
LMNA P02545 1/20 0.61
TP53 P04637 1/20 0.61
HTT P42858 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
RXFP1 Q9HBX9 1/20 0.61
PDE2A O00408 1/20 0.60
ADRA1A P35348 1/20 0.60
NT5E P21589 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3437025 1.00 ADORA2A (1.00) ADORA2AADORA3ADORA1ADORA2BADA
SCHEMBL30262576 1.00 ADORA2A (1.00) ADORA2AADORA3ADORA1ADORA2BADA
SCHEMBL16480951 0.89 ADORA2A (0.80) ADORA2AADORA3ADORA1ADORA2BADA
SCHEMBL10169502 0.89 ADORA2A (0.80) ADORA2AADORA3ADORA1ADORA2BADA
SCHEMBL15908433 0.89 ADORA2A (0.80) ADORA2AADORA3ADORA1ADORA2BADA
SCHEMBL873738 0.89 ADORA2A (0.80) ADORA2AADORA3ADORA1ADORA2BADA
SCHEMBL14589609 0.89 ADORA2A (0.80) ADORA2AADORA3ADORA1ADORA2BADA
SCHEMBL474849 0.89 ADORA2A (0.80) ADORA2AADORA3ADORA1ADORA2BADA
SCHEMBL10137892 0.89 ADORA2A (0.80) ADORA2AADORA3ADORA1ADORA2BADA
SCHEMBL29815502 0.88 ADORA2A (0.79) ADORA2AADORA3ADORA1ADORA2BADA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111848711-A 2' -chloronucleoside analogs for HCV infection 埃迪尼克斯医药有限责任公司 2020-10-30 CN disclosed